Michelle L Basil Haemonetics Corp (HAE) insider trading activity

Michelle L Basil is EVP and General Counsel of HAEMONETICS CORP. Currently has a direct ownership of 31,257 shares of HAE, which is worth approximately $2.42 Million. The most recent transaction as insider was on May 29, 2024, when has been sold 12,990 shares (Common Stock) at a price of $88.22 per share, resulting in proceeds of $1,145,977. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.3K

0% 3M change

3.15% 12M change

Total Value Held $2.42 Million

Michelle L Basil Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 29 2024	SELL Open market or private sale	$1,145,977 $88.22 p/Share	12,990 Reduced 29.36%	31,257 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$1,125,593 $95.73 p/Share	11,758 Reduced 20.99%	44,247 Common Stock
May 28 2024	BUY Grant, award, or other acquisition	-	24,748 Added 30.65%	56,005 Common Stock
May 20 2024	SELL Open market or private sale	$152,508 $95.08 p/Share	1,604 Reduced 4.88%	31,257 Common Stock
May 17 2024	SELL Payment of exercise price or tax liability	$64,043 $95.73 p/Share	669 Reduced 2.28%	28,683 Common Stock
May 17 2024	SELL Open market or private sale	$101,935 $95.0 p/Share	1,073 Reduced 3.53%	29,352 Common Stock
May 17 2024	BUY Grant, award, or other acquisition	-	4,178 Added 11.28%	32,861 Common Stock
May 16 2024	SELL Open market or private sale	$94,697 $96.14 p/Share	985 Reduced 3.14%	30,425 Common Stock
May 16 2024	SELL Payment of exercise price or tax liability	$42,280 $94.8 p/Share	446 Reduced 1.4%	31,410 Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$40,139 $96.49 p/Share	416 Reduced 1.29%	31,856 Common Stock
Oct 20 2023	SELL Payment of exercise price or tax liability	$17,542 $89.05 p/Share	197 Reduced 0.61%	32,272 Common Stock
May 18 2023	SELL Payment of exercise price or tax liability	$295,106 $83.34 p/Share	3,541 Reduced 9.83%	32,469 Common Stock
May 16 2023	SELL Payment of exercise price or tax liability	$39,787 $89.21 p/Share	446 Reduced 1.22%	36,010 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	-	4,205 Added 10.34%	36,456 Common Stock
May 12 2023	SELL Payment of exercise price or tax liability	$17,984 $88.16 p/Share	204 Reduced 0.63%	32,251 Common Stock
Oct 24 2022	SELL Open market or private sale	$14,470 $80.39 p/Share	180 Reduced 0.55%	32,455 Common Stock
Sep 19 2022	SELL Open market or private sale	$897,065 $78.36 p/Share	11,448 Reduced 25.97%	32,635 Common Stock
Sep 19 2022	BUY Exercise of conversion of derivative security	$395,738 $45.55 p/Share	8,688 Added 16.46%	44,083 Common Stock
Sep 15 2022	SELL Open market or private sale	$2,640,638 $78.13 p/Share	33,798 Reduced 48.85%	35,395 Common Stock
Sep 15 2022	BUY Exercise of conversion of derivative security	$1,300,817 $45.55 p/Share	28,558 Added 29.22%	69,193 Common Stock
Jun 13 2022	SELL Open market or private sale	$17,340 $62.6 p/Share	277 Reduced 0.68%	40,635 Common Stock
May 19 2022	SELL Open market or private sale	$192,548 $59.1 p/Share	3,258 Reduced 7.38%	40,912 Common Stock
May 16 2022	SELL Open market or private sale	$10,996 $56.1 p/Share	196 Reduced 0.51%	38,094 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	-	6,076 Added 12.09%	44,170 Common Stock
Oct 25 2021	SELL Open market or private sale	$8,632 $71.93 p/Share	120 Reduced 0.31%	38,290 Common Stock

MLB

Michelle L Basil

EVP and General Counsel

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HAE shares.

Notify only if

Value

Insider Trading

Get notified when an Haemonetics Corp insider buys or sells HAE shares.

Notify only if

Operation

Value

Type

News

Receive news related to HAEMONETICS CORP

Track Activities on HAE

Account